(Q46910457)

English

Total body irradiation, fludarabine, melphalan, and allogeneic hematopoietic stem cell transplantation for advanced pediatric hematologic malignancies

scientific article published in March 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16435013

Total body irradiation, fludarabine, melphalan, and allogeneic hematopoietic stem cell transplantation for advanced pediatric hematologic malignancies (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16435013

author name string

Petropoulos D

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16435013

Worth LL

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16435013

Mullen CA

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16435013

Madden R

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16435013

Mahajan A

5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16435013

Choroszy M

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16435013

Ha CS

7

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16435013

Champlin RC

8

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16435013

Chan KW

9

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16435013

language of work or name

0 references

publication date

1 March 2006

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16435013

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16435013

37

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16435013

5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16435013

463-467

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16435013

Cellular and clinical pharmacology of fludarabine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705278

21 January 2018

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705278

21 January 2018

Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705278

21 January 2018

Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705278

21 January 2018

Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705278

21 January 2018

Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705278

21 January 2018

Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705278

21 January 2018

Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705278

21 January 2018

Fludarabine-related pulmonary toxicity: a distinct clinical entity in chronic lymphoproliferative syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705278

21 January 2018

Outcome of allogeneic bone marrow transplantation for children with advanced acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705278

21 January 2018

Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705278

21 January 2018

Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705278

21 January 2018

Unrelated donor bone marrow transplantation for children with acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705278

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705278

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705278

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705278

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose (550 cGy), single-exposure total body irradiation and cyclophosphamide: consistent, durable engraftment of related-donor peripheral blood stem cells with low treatment-related mortality and fatal organ toxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705278

7 January 2021

based on heuristic

inferred from DOI database lookup

Regimen-related toxicity in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705278

7 January 2021

based on heuristic

inferred from DOI database lookup

Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemothe

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705278

7 January 2021

based on heuristic

inferred from DOI database lookup

Cord blood transplantation for children with acute leukaemia: a Eurocord registry analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705278

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and Immunology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705278

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematopoietic stem cell transplantation for childhood myeloid malignancies after high-dose thiotepa, busulfan and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705278

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1705278

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16435013

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16435013

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46910457&oldid=2208239859"